Award-winning hair transplant specialist launches groundbreaking campaign to commercialize innovative stem cell therapy for ...

Led by HYDE's founder, Sergey Baburov, the new solution leverages technology to optimize the full suppy chain, including ...

Thomson Reuters (TSX/Nasdaq: TRI) announced today its first-quarter 2025 Earnings will be issued via news release on Thursday, May 1, 2025. Thomson Reuters (TSX/Nasdaq: TRI), a global content and ...

Thomson Reuters Corporation operates as a content and technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through five segments: Legal ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

OneSource Specialty Pharma Limited, an Indian contract development and manufacturing organisation (CDMO), is gearing up to capture a 15-20% share in the generic GLP-1 market by FY27-28, betting on ...

WASHINGTON, April 2 (Reuters) - President Donald Trump's approval rating fell to 43%, the lowest since his return to office, as Americans soured on his tariff moves and his administration's ...

Max Junestrand says his legal tech startup, Legora, is gaining ground on Harvey with less money and fewer people.

Involves transaction of at least 0.5% of the listed shares of a company. OneSource Specialty Pharma Ltd share price was down by -2.33% from the previous closing price of ₹1,629.20. Who are peers ...

The superannuation sector has become a major driver of spending, so a market meltdown could flow through to the broader economy in a way we haven’t seen before.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.